nach oben

Journal of Inherited Metabolic Disease

Erschienen in:

18.07.2018 | Original Article

Presynaptic disorders: a clinical and pathophysiological approach focused on the synaptic vesicle

verfasst von: Elisenda Cortès-Saladelafont, Noa Lipstein, Àngels García-Cazorla

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

The aim of this report is to present a tentative clinical and pathophysiological approach to diseases affecting the neuronal presynaptic terminal, with a major focus on synaptic vesicles (SVs). Diseases are classified depending on which step of the neurobiology of the SV is predominantly affected: (1) biogenesis of vesicle precursors in the neuronal soma; (2) transport along the axon; (3) vesicle cycle at the presynaptic terminal (exocytosis–endocytosis cycle, with the main purpose of neurotransmitter release). Given that SVs have been defined as individual organelles, we highlight the link between the biological processes disturbed by genetic mutations and the clinical presentation of these disorders. The great majority of diseases may present as epileptic encephalopathies, intellectual disability (syndromic or nonsyndromic) with/without autism spectrum disorder (and other neuropsychiatric symptoms), and movement disorders. These symptoms may overlap and present in patients as a combination of clinical signs that results in the spectrum of the synaptopathies. A small number of diseases may also exhibit neuromuscular signs. In general, SV disorders tend to be severe, early encephalopathies that interfere with neurodevelopment. As a consequence, developmental delay and intellectual disability are constant in almost all the defects described. Considering that some of these diseases might mimic other neurometabolic conditions (and in particular treatable disorders), an initial extensive metabolic workup should always be considered. Further knowledge into pathophysiological mechanisms and biomarkers, as well as descriptions of new presynaptic disorders, will probably take place in the near future.

Abou Jamra R, Philippe O, Raas-Rothschild A et al (2011) Adaptor protein complex 4 deficiency causes severe autosomal-recessive intellectual disability, progressive spastic paraplegia, shy character, and short stature. Am J Hum Genet 88:788–795CrossRefPubMedPubMedCentral

Alfieri A, Sorokina O, Adrait A et al (2017) Synaptic Interactome mining reveals p140Cap as a new hub for PSD proteins involved in psychiatric and neurological disorders. Front Mol Neurosci 10:212CrossRefPubMedPubMedCentral

Anikster Y, Haack TB, Vilboux T et al (2017) Biallelic mutations in DNAJC12 cause Hyperphenylalaninemia, dystonia, and intellectual disability. Am J Hum Genet 100:257–266CrossRefPubMedPubMedCentral

Baker K, Gordon SL, Grozeva D et al (2015) Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling. J Clin Invest 125:1670–1678PubMedPubMedCentral

Bem D, Yoshimura S, Nunes-Bastos R et al (2011) Loss-of-function mutations in RAB18 cause Warburg micro syndrome. Am J Hum Genet 88:499–507CrossRefPubMedPubMedCentral

Bilo L, Peluso S, Antenora A et al (2014) Parkinsonism may be part of the symptom complex of DOOR syndrome. Parkinsonism Relat Disord 20:463–465CrossRefPubMed

Bonifati V, Rizzu P, van Baren MJ et al (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256–259CrossRefPubMed

Cavallin M, Hubert L, Cantagrel V et al (2016) Recurrent KIF5C mutation leading to frontal pachygyria without microcephaly. Neurogenetics 17:79–82CrossRefPubMed

Chang FC, Westenberger A, Dale RC et al (2016) Phenotypic insights into ADCY5-associated disease. Mov Disord 31:1033–1040CrossRefPubMedPubMedCentral

Cirnaru MD, Marte A, Belluzzi E et al (2014) LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex. Front Mol Neurosci 7:49CrossRefPubMedPubMedCentral

Conroy J, Allen NM, Gorman KM et al (2016) NAPB - a novel SNARE-associated protein for early-onset epileptic encephalopathy. Clin Genet 89:E1–E3CrossRefPubMed

Corbett MA, Schwake M, Bahlo M et al (2011) A mutation in the Golgi Qb-SNARE gene GOSR2 causes progressive myoclonus epilepsy with early ataxia. Am J Hum Genet 88:657–663CrossRefPubMedPubMedCentral

Corradi A, Fadda M, Piton A et al (2014) SYN2 is an autism predisposing gene: loss-of-function mutations alter synaptic vesicle cycling and axon outgrowth. Hum Mol Genet 23:90–103CrossRefPubMed

Cortès-Saladelafont E, Tristán-Noguero A, Artuch R et al (2016) Diseases of the synaptic vesicle: a potential new group of neurometabolic disorders affecting neurotransmission. Semin Pediatr Neurol 23(4):306–320CrossRefPubMed

Cross-Disorder Group of the Psychiatric Genomics C (2013) Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381:1371–1379CrossRef

De Rubeis S, He X, Goldberg AP et al (2014) Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515:209–215CrossRefPubMedPubMedCentral

Diez H, Cortes-Saladelafont E, Ormazabal A et al (2017) Severe infantile parkinsonism because of a de novo mutation on DLP1 mitochondrial-peroxisomal protein. Mov Disord 32:1108–1110CrossRefPubMed

Doi H, Yoshida K, Yasuda T et al (2011) Exome sequencing reveals a homozygous SYT14 mutation in adult-onset, autosomal-recessive spinocerebellar ataxia with psychomotor retardation. Am J Hum Genet 89:320–327CrossRefPubMedPubMedCentral

Doummar D, Mignot C, Apartis E et al (2015) A novel homozygous TBC1D24 mutation causing multifocal myoclonus with cerebellar involvement. Mov Disord 30:1431–1432CrossRef

Drouet V, Lesage S (2014) Synaptojanin 1 mutation in Parkinson’s disease brings further insight into the neuropathological mechanisms. Biomed Res Int 2014:289728CrossRefPubMedPubMedCentral

Ebrahimi-Fakhari D, Saffari A, Westenberger A, Klein C (2015) The evolving spectrum of PRRT2-associated paroxysmal diseases. Brain 138:3476–3495CrossRefPubMed

Falace A, Filipello F, La Padula V et al (2010) TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy. Am J Hum Genet 87:365–370CrossRefPubMedPubMedCentral

Fassio A, Patry L, Congia S et al (2011) SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum Mol Genet 20:2297–2307CrossRefPubMed

Fernandes AC, Uytterhoeven V, Kuenen S et al (2014) Reduced synaptic vesicle protein degradation at lysosomes curbs TBC1D24/sky-induced neurodegeneration. J Cell Biol 207:453–462CrossRefPubMedPubMedCentral

Fromer M, Pocklington AJ, Kavanagh DH et al (2014) De novo mutations in schizophrenia implicate synaptic networks. Nature 506:179–184CrossRefPubMedPubMedCentral

Fuchs-Telem D, Stewart H, Rapaport D et al (2011) CEDNIK syndrome results from loss-of-function mutations in SNAP29. Br J Dermatol 164:610–616PubMed

Gai X, Xie HM, Perin JC et al (2012) Rare structural variation of synapse and neurotransmission genes in autism. Mol Psychiatry 17:402–411CrossRefPubMed

Garcia CC, Blair HJ, Seager M et al (2004) Identification of a mutation in synapsin I, a synaptic vesicle protein, in a family with epilepsy. J Med Genet 41:183–186CrossRefPubMedPubMedCentral

García-Cazorla A, Saudubray JM (2018) Cellular neurometabolism: a tentative to connect cell biology and metabolism in neurology. J Inher Metab Dis. https://doi.org/10.1007/s10545-018-0226-8

Gardiner AR, Jaffer F, Dale RC et al (2015) The clinical and genetic heterogeneity of paroxysmal dyskinesias. Brain 138:3567–3580CrossRefPubMedPubMedCentral

Giovedi S, Corradi A, Fassio A, Benfenati F (2014) Involvement of synaptic genes in the pathogenesis of autism spectrum disorders: the case of synapsins. Front Pediatr 2:94PubMedPubMedCentral

Gonzalez-Jamett AM, Haro-Acuna V, Momboisse F, Caviedes P, Bevilacqua JA, Cardenas AM (2014) Dynamin-2 in nervous system disorders. J Neurochem 128:210–223CrossRefPubMed

Gupta HV, Vengoechea J, Sahaya K, Virmani T (2015) A splice site mutation in ATP6AP2 causes X-linked intellectual disability, epilepsy, and parkinsonism. Parkinsonism Relat Disord 21:1473–1475CrossRefPubMed

Herrmann DN, Horvath R, Sowden JE et al (2014) Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-Eaton myasthenic syndrome and nonprogressive motor neuropathy. Am J Hum Genet 95:332–339CrossRefPubMedPubMedCentral

Jamuar SS, Lam AT, Kircher M et al (2014) Somatic mutations in cerebral cortical malformations. N Engl J Med 371:733–743CrossRefPubMedPubMedCentral

Karamohamed S, Golbe LI, Mark MH et al (2005) Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson’s disease from the GenePD study. Mov Disord 20:1188–1191CrossRefPubMed

Kitada T, Asakawa S, Hattori N et al (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605–608CrossRefPubMed

Koutsopoulos OS, Kretz C, Weller CM et al (2013) Dynamin 2 homozygous mutation in humans with a lethal congenital syndrome. Eur J Hum Genet 21:637–642CrossRefPubMed

Kumar RA, Sudi J, Babatz TD et al (2010) A de novo 1p34.2 microdeletion identifies the synaptic vesicle gene RIMS3 as a novel candidate for autism. J Med Genet 47:81–90CrossRefPubMed

Lim DS, Kirsch DG, Canman CE et al (1998) ATM binds to beta-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci U S A 95:10146–10151CrossRefPubMedPubMedCentral

Lipstein N, Verhoeven-Duif NM, Michelassi FE et al (2017) Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder. J Clin Invest 127:1005–1018CrossRefPubMedPubMedCentral

Maritzen T, Haucke V (2017) Coupling of exocytosis and endocytosis at the presynaptic active zone. Neurosci Res

Milh M, Falace A, Villeneuve N et al (2013) Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy. Hum Mutat 34:869–872CrossRefPubMed

Miyaji T, Echigo N, Hiasa M, Senoh S, Omote H, Moriyama Y (2008) Identification of a vesicular aspartate transporter. Proc Natl Acad Sci U S A 105:11720–11724CrossRefPubMedPubMedCentral

Mochel F (2018) Lipids and synaptic function. J Inherit Metab Dis. https://doi.org/10.1007/s10545-018-0204-1

Montecchiani C, Pedace L, Lo Giudice T et al (2016) ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease. Brain 139:73–85CrossRefPubMed

Nakashima M, Kouga T, Lourenco CM et al (2016) De novo DNM1 mutations in two cases of epileptic encephalopathy. Epilepsia 57:e18–e23CrossRefPubMed

Nguyen HT, Bryois J, Kim A et al (2017) Integrated Bayesian analysis of rare exonic variants to identify risk genes for schizophrenia and neurodevelopmental disorders. Genome Med 9:114CrossRefPubMedPubMedCentral

Okamoto N, Miya F, Tsunoda T et al (2014) KIF1A mutation in a patient with progressive neurodegeneration. J Hum Genet 59:639–641CrossRefPubMed

Olgiati S, Quadri M, Fang M et al (2016) DNAJC6 mutations associated with early-onset Parkinson’s disease. Ann Neurol 79:244–256CrossRefPubMed

Orlacchio A, Babalini C, Borreca A et al (2010) SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain 133:591–598CrossRefPubMedPubMedCentral

Peeraully T, Tan EK (2012) Genetic variants in sporadic Parkinson’s disease: east vs west. Parkinsonism Relat Disord 18(Suppl 1):S63–S65CrossRefPubMed

Piton A, Michaud JL, Peng H et al (2008) Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet 17:3965–3974CrossRefPubMed

Rafiq MA, Leblond CS, Saqib MA et al (2015) Novel VPS13B mutations in three large Pakistani Cohen syndrome families suggests a Baloch variant with autistic-like features. BMC Med Genet 16:41CrossRefPubMedPubMedCentral

Ramirez A, Heimbach A, Grundemann J et al (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38:1184–1191CrossRefPubMed

Reid E, Kloos M, Ashley-Koch A et al (2002) A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 71:1189–1194CrossRefPubMedPubMedCentral

Rilstone JJ, Alkhater RA, Minassian BA (2013) Brain dopamine-serotonin vesicular transport disease and its treatment. N Engl J Med 368:543–550CrossRefPubMed

Rizzoli SO (2014) Synaptic vesicle recycling: steps and principles. EMBO J 33:788–822CrossRefPubMedPubMedCentral

Rohena L, Neidich J, Truitt Cho M et al (2013) Mutation in SNAP25 as a novel genetic cause of epilepsy and intellectual disability. Rare Dis 1:e26314CrossRefPubMedPubMedCentral

Roland BP, Zeccola AM, Larsen SB et al (2016) Structural and genetic studies demonstrate neurologic dysfunction in triosephosphate isomerase deficiency is associated with impaired synaptic vesicle dynamics. PLoS Genet 12:e1005941CrossRefPubMedPubMedCentral

Sarper N, Zengin E, Jakobs C et al (2013) Mild hemolytic anemia, progressive neuromotor retardation and fatal outcome: a disorder of glycolysis, triose- phosphate isomerase deficiency. Turk J Pediatr 55:198–202PubMed

Schneider AS, Valentine WN, Hattori M, Heins HL Jr (1965) Hereditary hemolytic anemia with triosephosphate isomerase deficiency. N Engl J Med 272:229–235CrossRefPubMed

Schubert J, Siekierska A, Langlois M et al (2014) Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes. Nat Genet 46:1327–1332CrossRefPubMed

Scoto M, Rossor AM, Harms MB et al (2015) Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophy. Neurology 84:668–679CrossRefPubMedPubMedCentral

Serajee FJ, Huq AM (2015) Homozygous mutation in synaptic vesicle glycoprotein 2A gene results in intractable epilepsy, involuntary movements, microcephaly, and developmental and growth retardation. Pediatr Neurol 52:642–646.e641CrossRefPubMed

Shen XM, Selcen D, Brengman J, Engel AG (2014) Mutant SNAP25B causes myasthenia, cortical hyperexcitability, ataxia, and intellectual disability. Neurology 83:2247–2255CrossRefPubMedPubMedCentral

Sinajon P, Verbaan D, So J (2016) The expanding phenotypic spectrum of female SLC9A6 mutation carriers: a case series and review of the literature. Hum Genet 135:841–850CrossRefPubMed

Soykan T, Maritzen T, Haucke V (2016) Modes and mechanisms of synaptic vesicle recycling. Curr Opin Neurobiol 39:17–23CrossRefPubMed

Sprecher E, Ishida-Yamamoto A, Mizrahi-Koren M et al (2005) A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma. Am J Hum Genet 77:242–251CrossRefPubMedPubMedCentral

Stamberger H, Nikanorova M, Willemsen MH et al (2016) STXBP1 encephalopathy: a neurodevelopmental disorder including epilepsy. Neurology 86:954–962CrossRefPubMed

Stevanin G, Santorelli FM, Azzedine H et al (2007) Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet 39:366–372CrossRefPubMed

Stockler S, Corvera S, Lambright D et al (2014) Single point mutation in Rabenosyn-5 in a female with intractable seizures and evidence of defective endocytotic trafficking. Orphanet J Rare Dis 9:141CrossRefPubMedPubMedCentral

Straniero L, Guella I, Cilia R et al (2017) DNAJC12 and dopa-responsive nonprogressive parkinsonism. Ann Neurol 82:640–646CrossRefPubMed

Sudhof TC (2013) Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron 80:675–690CrossRefPubMed

Takamori S, Holt M, Stenius K et al (2006) Molecular anatomy of a trafficking organelle. Cell 127:831–846CrossRefPubMed

Thomas AC, Williams H, Seto-Salvia N et al (2014) Mutations in SNX14 cause a distinctive autosomal-recessive cerebellar ataxia and intellectual disability syndrome. Am J Hum Genet 95:611–621CrossRefPubMedPubMedCentral

Tristán-Noguero A, García-Cazorla A (2018) Synaptic metabolism: a new approach to inborn errors of neurotransmission. J Inherit Metab Dis. https://doi.org/10.1007/s10545-018-0235-7

Valente EM, Abou-Sleiman PM, Caputo V et al (2004) Hereditary early-onset Parkinson’s disease caused by mutations in PINK1. Science 304:1158–1160CrossRefPubMed

Verheijen FW, Verbeek E, Aula N et al (1999) A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nat Genet 23:462–465CrossRefPubMed

Verkerk AJ, Schot R, Dumee B et al (2009) Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy. Am J Hum Genet 85:40–52CrossRefPubMedPubMedCentral

Vilarino-Guell C, Rajput A, Milnerwood AJ et al (2014) DNAJC13 mutations in Parkinson disease. Hum Mol Genet 23:1794–1801CrossRefPubMed

Wilmshurst JM, Wise GA, Pollard JD, Ouvrier RA (2004) Chronic axonal neuropathy with triosephosphate isomerase deficiency. Pediatr Neurol 30:146–148CrossRefPubMed

Wilson GR, Sim JC, McLean C et al (2014) Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with alpha-synuclein pathology. Am J Hum Genet 95:729–735CrossRefPubMedPubMedCentral

Wojcik SM, Brose N (2007) Regulation of membrane fusion in synaptic excitation-secretion coupling: speed and accuracy matter. Neuron 55:11–24CrossRefPubMed

Yokoi F, Cheetham CC, Campbell SL, Sweatt JD, Li Y (2013) Presynaptic release deficits in a DYT1 dystonia mouse model. PLoS One 8:e72491CrossRefPubMedPubMedCentral

Titel: Presynaptic disorders: a clinical and pathophysiological approach focused on the synaptic vesicle
verfasst von: Elisenda Cortès-Saladelafont
Noa Lipstein
Àngels García-Cazorla
Publikationsdatum: 18.07.2018
Verlag: Springer Netherlands
Erschienen in: Journal of Inherited Metabolic Disease / Ausgabe 6/2018
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI: https://doi.org/10.1007/s10545-018-0230-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2018

Spectrum of movement disorders and neurotransmitter abnormalities in paediatric POLG disease

Sirtuin signaling controls mitochondrial function in glycogen storage disease type Ia

Dental and periodontal manifestations of glycogen storage diseases: a case series of 60 patients

View from inside

Craniosynostosis affects the majority of mucopolysaccharidosis patients and can contribute to increased intracranial pressure